Liver International

Liver cancer stem cells: implications for a new therapeutic target
pp. 955-965(11)
Authors: Lee, Terence Kin Wah; Castilho, Antonia; Ma, Stephanie; Ng, Irene Oi Lin

Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin
pp. 966-978(13)
Authors: Hartland, Stephen N.; Murphy, Frank; Aucott, Rebecca L.; Abergel, Armand; Zhou, Xiaoying; Waung, Julian; Patel, Nishit; Bradshaw, Catherine; Collins, Jane; Mann, Derek; Benyon, R. Christopher; Iredale, John P.

Impaired liver regeneration with humoral and genetic disturbances in urinary trypsin inhibitor-deficient mice
pp. 979-987(9)
Authors: Nobuoka, Takayuki; Mizuguchi, Toru; Oshima, Hideki; Shibata, Toshihito; Kaji, Shinsuke; Nagayama, Minoru; Meguro, Makoto; Mitaka, Toshihiro; Hirata, Koichi

Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
pp. 988-996(9)
Authors: Kudo, Hiroshi; Yata, Yutaka; Takahara, Terumi; Kawai, Kengo; Nakayama, Yasuhiro; Kanayama, Masami; Oya, Takeshi; Morita, Seiichi; Sasahara, Masakiyo; Mann, Derek A.; Sugiyama, Toshiro

Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice
pp. 997-1009(13)
Authors: Latella, Giovanni; Vetuschi, Antonella; Sferra, Roberta; Catitti, Valentina; D'Angelo, Angela; Zanninelli, Giuliana; Flanders, Kathleen C.; Gaudio, Eugenio

Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes
pp. 1010-1021(12)
Authors: Copple, Bryan L.; Bustamante, Juan J.; Welch, Timothy P.; Kim, Nam Deuk; Moon, Jeon-Ok

Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation
pp. 1022-1030(9)
Authors: Atta, Hussein M.; Al-Hendy, Ayman; Salama, Salama A.; Shaker, Olfat G.; Hammam, Olfat A.

Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression
pp. 1031-1042(12)
Authors: Fava, Giammarco; DeMorrow, Sharon; Gaudio, Eugenio; Franchitto, Antonio; Onori, Paolo; Carpino, Guido; Glaser, Shannon; Francis, Heather; Coufal, Monique; Marucci, Luca; Alvaro, Domenico; Marzioni, Marco; Horst, Trenton; Mancinelli, Romina; Benedetti, Antonio; Alpini, Gianfranco

Esophageal variceal bleeding in a patient with tuberculosis
pp. 1043-1043(1)
Authors: Lin, Chih-Feng; Yi-Chen Hsu, Rich; Hsieh, Tsai-Yuan; Chu, Heng-Cheng

Diabetic hepatosclerosis: a 10-year autopsy series
pp. 1044-1050(7)
Authors: Chen, Guilan; Brunt, Elizabeth M.

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection
pp. 1051-1055(5)
Authors: Alvarez-Uria, Gerardo; Day, Jeremy N.; Nasir, Anisa J.; Russell, Susan K.; Vilar, Francisco Javier

The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma
pp. 1056-1064(9)
Authors: Takai, Hirotake; Kato, Atsuhiko; Kato, Chie; Watanabe, Takeshi; Matsubara, Koichi; Suzuki, Masami; Kataoka, Hiroaki

Schistosoma mansoni coinfection could have a protective effect against mixed cryoglobulinaemia in hepatitis C patients
pp. 1065-1070(6)
Authors: Abbas, Omaima M.; Omar, Nabil A.; Zaghla, Hassan E.; Faramawi, Mohammad F.

Effect of hyponatraemia on outcomes following orthotopic liver transplantation
pp. 1071-1077(7)
Authors: Hackworth, William A.; Heuman, Douglas M.; Sanyal, Arun J.; Fisher, Robert A.; Sterling, Richard K.; Luketic, Velimir A.; Shiffman, Mitchell L.; Maluf, Daniel G.; Cotterell, Adrian H.; Posner, Marc P.; Stravitz, Richard T.

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease
pp. 1078-1085(8)
Authors: Yoneda, Masato; Hotta, Kikuko; Nozaki, Yuichi; Endo, Hiroki; Uchiyama, Takashi; Mawatari, Hironori; Iida, Hiroshi; Kato, Shingo; Fujita, Koji; Takahashi, Hirokazu; Kirikoshi, Hiroyuki; Kobayashi, Noritoshi; Inamori, Masahiko; Abe, Yasunobu; Kubota, Kensuke; Saito, Satoru; Maeyama, Shiro; Wada, Koichiro; Nakajima, Atsushi

Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C
pp. 1086-1093(8)
Authors: Hung, Chao-Hung; Lee, Chuan-Mo; Chen, Chien-Hung; Hu, Tsung-Hui; Jiang, Shu-Rong; Wang, Jing-Houng; Lu, Sheng-Nan; Wang, Pei-Wei

Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease
pp. 1094-1100(7)
Authors: Silveira, Marina G.; Mendes, Flavia D.; Diehl, Nancy N.; Enders, Felicity T.; Lindor, Keith D.

Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial
pp. 1101-1109(9)
Authors: Chen, Lei; Xiao, Tianli; Chen, Wensheng; Long, Qingling; Li, Rongjun; Fang, Dianchun; Wang, Rongquan

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study
pp. 1110-1115(6)
Authors: Tandon, Puneeta; Moncrief, Karli; Madsen, Karen; Arrieta, Marie C.; Owen, Richard J.; Bain, Vince G.; Wong, Winnie W.; Ma, Mang M.

A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice)
pp. 1116-1124(9)
Authors: Gåfvels, Mats; Holmström, Petra; Somell, Anna; Sjövall, Fredrik; Svensson, Jan-Olof; Ståhle, Lars; Broomé, Ulrika; Stål, Per

Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver
pp. 1125-1125(1)
Authors: Kapoor, Sorabh; Bahde, Ralf

Re: Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver
pp. 1125-1126(2)
Authors: Yu, Jun; Chu, Eagle S. H.

Which level of immunosuppression is harmful for occult hepatitis B virus infection?
pp. 1126-1127(2)
Author: Ozaslan, Ersan

Which level of immunosuppression is harmful for occult hepatitis B virus infection?: `A million dollar' answer
pp. 1127-1128(2)
Authors: Georgiadou, Sarah P.; Dalekos, George N.